ICMRA Recommends Regulatory Bodies Continue Using the Remote Inspections Begun in the Pandemic

A global coalition of regulators has recommended permanent use of the remote inspections of drug manufacturing plants that regulatory bodies began to use during the COVID-19 pandemic.
Source: Drug Industry Daily